Pandemic has brought new sense of awareness to respiratory diseases and clinops.
Susan Wood, PhD
Advertisement
President & CEO of VIDA Diagnostics
Articles by Susan Wood, PhD
Steps that investigators and sponsors can take to streamline trials and accelerate the time to market for lifesaving therapies.
Advertisement
Latest Updated Articles
- Streamlining the Complex Respiratory Clinical Trial Infrastructure
November 29th 2021
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5